To read more on this topic click here.
Parkinson’s gene therapy could improve motor symptoms
News
Author: Simge Eva DoganPublished: 14 November 2018
Prep:
Cook:
Serves:
UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.
The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.
The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.
For more information on Parkinson’s and gene therapy please visit the EPDA website.
Read more:
Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs
AI technology could diagnose Parkinson’s in less than three minutes
Last Month
Next Month
Share this story
Related articles
Interviews
Pedalling for Parkinson’s
We talk to the founder of The Bike Box Project in New Bern, North Carolina
READ MORE
Global update
5 inspirational moments from the World Parkinson Congress 2016
More than 4,600 people from 67 different countries came together in Portlan
READ MORE
Global update
Ozzy Osbourne: “I’ve owned up to the fact that I have Parkinson’s”
The Black Sabbath singer thanks his fans for their support
READ MORE
Comments